Pure Global
NCT06368102

Prophylactic Effects for Preventing Surgical Site Infection in Third Molar Surgery

Prophylactic Effects of Different Duration of Intravenous Ampicillin for Preventing Surgical Site Infection in Third Molar Surgery: a Randomized Controlled Trial
Uji Takeda Hospital·Phase 4·ClinicalTrials.gov·drugRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Surgical Site Infection
Drug/Device/Intervention
Ampicillin
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Uji Takeda Hospital
Location
Uji, Japan
Timeline & enrollment
Phase
Phase 4
Start date
May 02, 2024
End date
Aug 01, 2025
Enrollment
70 participants
Primary outcome

Occurrence of surgical site infection

Summary

The purpose of this study is to determine the incidence of surgical site infection (SSIs)
 after third molar surgery for different duration of intravenous ampicillin administration.

ICD-10 classifications
Infection following a procedure, not elsewhere classifiedBacterial infection of unspecified siteOther bacterial infections of unspecified siteInfection of obstetric surgical woundOther specified local infections of skin and subcutaneous tissue
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06368102
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06368102 through Pure Global AI's free database. This Phase 4 trial is sponsored by Uji Takeda Hospital and is currently Recruiting. The study focuses on Surgical Site Infection. Target enrollment is 70 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.